| Date |
Report No. |
Title |
| Date July 9, 1991 |
Report No. PEMD-91-19 |
Title
3 c3 cI ^.i _.__. . I^ ._... i^. ._._ . ..- _ ...__I.. .-~..- . ..-._._ - ..--. -_- ._.---...... ..-...-.. ’ GAO Gemeral Accounting OffIce WaUngton, D.C. 20648 Program Evaluation aud Methodology Division unit.4ld states I B-243616 July 9,lQQl The Honorable John D. Dingell Chairman, Subcommitteeon Oversight and Investigations Committee on Energy and Commerce House of Representatives Dear Mr. Chai... |
| Date March 7, 1991 |
Report No. T-IMTEC-91-5 |
Title
GAO a. Testimony /y3n-7 IIIIll II Ill1
143857 For Release on Delivery Supercomputing in Industry Expectedat 9:30 a.m, EST Thursday March 7, 1991 Statement the record by for Jack L. Erock, Jr., Director Government Information and FinancialManagement Issues Information Management TechnologyDivision and Before the Subcommittee Technologyand Competitiveness on Committeeon Science,Space,and Technology ... |
| Date March 5, 1991 |
Report No. T-IMTEC-91-3 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 2:00 p.m. EST Tuesday March 5, 1991 Testimony Supercomputing in Industry Statement for the record by Jack L. Brock, Jr., Director, Government Information and Financial Management Issues Information Management and Technology Division Before the Subcommittee on Science, Technology, and Space Science, and Transportation C... |
| Date Feb. 25, 1991 |
Report No. PEMD-91-12BR |
Title
11 1;
Ji Jo t -- __...._ -----. ^.-- ______ -..._.__.__- _........ - United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-242851 February 25,199l The Honorable Edward M. Kennedy Chairman, Committee on Labor and Human Resources United States Senate Dear Mr. Chairman: In September 1989, you asked us to conduct a study on reimbursement denials ... |
| Date April 26, 1990 |
Report No. PEMD-90-15 |
Title
P United States General Accounting Office GAO
April 1990 Report to the Chairman, Subcommittee . on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives FDA DRUG REVIEW Postapproval Risks
1976-85 Not to be released outside the BESTRICTEDGeneral Accounting Office def38 SPeCme GAO/PEMD-90-15 United States General Accounting Office Washington, D... |
| Date Aug. 1, 1989 |
Report No. T-PEMD-89-5 |
Title
, United States General Accounting OilIce li GAO
For Release on Delivery Expected at 9:30 a.m. Tuesday I August 1, 1989 . Testimony lull llllllllll
139212 Drug Utilization Review Under Medicare Statement of Carl E. Wisler Director of Planning and Reporting Program Evaluation and Methodology Division Before the Subcommittee on HumanAffairs Select Committee on Aging House of Representatives GAO/T-PE... |
| Date July 13, 1989 |
Report No. PEMD-89-26BR |
Title
.,, I’( . ..b ,.1 *,.. *Jnxted States Cietiefai r.kcbuhtmg Uffice~ I ’ Briefing Report to the Chairman, Special Committee on Aging, U.S. Senate July 1989 PRESCRIPTION DRUGS HCFA’s Proposed Drug Utilization Review System Ignores Quality of Care Issues GAO/PEMD-89-26BR -- GAO United States General Accounting Office Washington, D.C. 20548 Program Evaluation and Methodology Division B-235298 Jul... |
| Date Feb. 23, 1988 |
Report No. NSIAD-88-120FS |
Title
-.I+_, ,,: .T .. k , -> ,& . tY;. _ *‘ 1 : ,,.I*; ., ‘ ~ “A,. lhad~Ge~Aa!oulm48omce Fact Sheet for the Honorable Lloyd M . Bentsen, U.S. Senate Febnmy 1998 US-JAPAN TRADE TradeData and IndustryViews on M O SSAgreements @SGXTED-Not to be releasedoutside the General Accmnting oRice except .on the basis of the ep&lc approval by_tbe cmca ofRelatiom GAO United States General Accounting OBice Wash... |
| Date Nov. 4, 1987 |
Report No. HRD-88-8 |
Title
United States Genekl Accounting Office w SC Report to the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, H&se of Representatives Novehber 1987 FOOD AND DRUG ADMINISTRATION HHS Inspector General Should Be Involved in Criminal Investigations 134332 040448
GAO/HRD88-8 --____- --I -- -- GA0 General ::::z:: Accounting OPPice C 9 .a 20548 Division Human Resources R-22914... |
| Date July 10, 1987 |
Report No. NSIAD-87-186BR |
Title
GAO
July 1987 Briefing Rep;iortto the Honorable -1’ Lloyd M. Bentsen, United States Senate U.S.-JA,PAN TRADE
l Interim Report on Sector-Selective Agreements GAO United States General Accounting OPBce Washington, D.C. 20548 National Security and International Affairs Division B-227630 July 10, 1987 The Honorable Lloyd M. Bentsen United States Senate Dear Senator Bentsen: On February 25, 1987, you... |
| Date Sept. 5, 1986 |
Report No. IMTEC-86-32 |
Title
. , 1 * ? United States General Accounting Office “GAO
September 1986 Report to the Chairman, Subcommittee on Intergovernmental Relations and Human Resources, Committee on Government Operations House of Representatives I DRUG REGULATION, FDA’s Computer Systems Need ,fb Be I Better Managed nl~llllln~~
131277 p#STPUIC~D-- Not, $0 be rdsnseb
Ofikk? Of o-3
icxiad~m. tho CfaXd Accounting approval b... |
| Date April 24, 1986 |
Report No. HRD-86-56 |
Title
Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce EIouseof Representatives
April l!M
‘. VETERANs
“. _ ___“._ ._.--....-.-__-_~---__-._--.~~~--.-~~ ... . .._. .._..-.-..... l..“l.. ._.” &Jnited States ..-... Accounting _.._-_. ._..... - _._.___._..: r.---.-_-____ Okfiee ..--.-- -----. ..-.. .--.. ._... M “. &&ml ..__... --_..___ -..--... |
| Date March 6, 1986 |
Report No. HRD-86-66 |
Title
\ J . ..A 1 I. \ I_ United States C&m&i Ackounting Office L deport to the Chief Medical Director, Veterans Administration . ..--A., Mardi 1986 ” VA HEALTH CARE : Opportunities Still’ Exist for Reducing Fee-BasisPharmacy costs, .-l-l_ ill llll~l~lll~~
129259 UnIted States General Accounting Off‘ice Waehington, D.C. 20548 Human Resourcea Divisfon
B-207920 March 6, 1986 Dr. John W. Ditzler Chie... |
| Date Sept. 27, 1983 |
Report No. HRD-83-83 |
Title
. . UNITED STATES GENERALACCOUNTIN&FFICE c
WASHINGTON, D C. 20548
HUMAN RESOURW DlVlSION SeotemDer 27, 1983 B-207930 The Honorable Administrator Harry N. Walters of Veterans Affairs Dear Xr. Walters: Sublect: Opportunltles to Xeduce Fee-Basis Pharmacy Costs (GAO/HRD-83-83) We have completed a review of the Veterans Adminxtratlon's (VA's1 efforts to reduce the number and cost of prescriptions fille... |
| Date April 5, 1983 |
Report No. HRD-83-24 |
Title
1. *.’ /ZlVc/l J ,‘$ a, - M+=t .’ BY THECOtiPTROLLEl? GENERAL Report To The Congress
OF THEUNITEDSTATES
LegislativcqBkd Administrative Changes Needed To Improve Regulation,JlYf Drug industry
A considerable amount of misbranded and adulterated drug products get on the market because the Food and Drug Administration (FDA) does not have legislative authority to detain the products administrativ... |
| Date April 26, 1982 |
Report No. HRD-82-41 |
Title
I. 1 L ,jej+$-f/ //g/q6 ’ BY THECOMPTROLLER GENERAL Report To The Congress
OF THEUNITEDSTATES
FDA’s Approach To Reviewing Over-The-Counter Drugs Is Reasonable, But Progress Is Slow
F’ederal law requires the Food and Drug Administration to ensure that drugs sold csver the counter are safe and effective. FDA has designed a reasonable approach to regulating this large market, where retail sales... |
| Date March 8, 1982 |
Report No. HRD-82-37 |
Title
Report To The Secretary Of Health And Human Services - FDA Can Further improve Its Adverse Drug Reaction Reporting System
The Food and Drug Administration has improved the use of its adverse drug reaction reporting system ,since GAO reported on it in 1974. Medical officers are more familiar with ‘the system and are using it more. However, improvements can still be made. Many adverse reaction rep... |
| Date Dec. 15, 1981 |
Report No. 116887 |
Title
. * t ' Address Presented to
25th. Annual Educational Conference
bY The Food and Drug Law I n s t i t u t e in Washington, D.C. on December 15-1 6 , 1981 Murray Grant, M.D., D.P.H. "PROGRESS AND PROBLEMS IN FDA'S DRUG APPROVAL PROCESS" PROGRESS AND PROBLEMS IN FDA'S DRUG APPROVAL PROCESS In My of l a s t year the GAO issued a report on the FDA's drug approval a process that followed almost 3 years... |
| Date Nov. 23, 1981 |
Report No. HRD-82-16 |
Title
Comptroller General
CiF THE UNITEDSTATES Speeding Up The Drug Review Ffrocess:Results Encouraging -E&t Progress Slow G ’0 is recommending actions that the Secreta of Health and Human Services could take to 4Yurther reduce drug review time. 117126 tj RD.8246 NOVEMBEdr 23,1981 Raquast for copies of GAO reports should be sent to: U.S. General Accounting Office Document Handling and Information Serv... |
| Date Sept. 16, 1981 |
Report No. 116350 |
Title
UNITED STATES GENERAL ACCOUNTING OFFICE WASHINGTON, D.C. 20548 FOR RELEASE ON DELIVERY Expected at 10:00 A.M. EDT September 16, 1981 STATEMENT OF EDWARD A. DENSMORE, DEPUTY DIRECTOR, HUMAN RESOURCES DIVISION BEFORE THE SUBCOMMITTEE ON NATURAL RESOURCES, AGRICULTURE RESEARCH AND ENVIRONMENT, HOUSE COMMITTEE ON SCIENCE AND TECHNOLOGY ON THE FOOD AND DRUG ADMINISTRATION'S EFFORTS TO SPEED UP THE DRUG... |
| Date July 17, 1981 |
Report No. HRD-81-125 |
Title
UNITED STATES GENERAL ACCOUNTINGOFFICE
WASHINGTON, D.C. 20548 HUMAN RESOURCES DIVISION B-202161 The Honorable Henry A. Waxman Subcommittee on Health Chairman, and the Environment Committee on Energy and Commerce House of Representatives Dear Mr. 115882 Chairman: -P----" "1) (HRD-81-125) Subject: Federal Drug Development Programs L J This is in response to your request that we develop information o... |
| Date April 20, 1981 |
Report No. HRD-81-61 |
Title
/--- I. .A/ cllj ( .,r- .--..‘I-\_I; :‘-r[:_ s’A\T’s I, . I
it. M. Goldwater, Jr. entatives al Cortical Extract Off Drug Market
In .,lanuary 1978, the Food and Drug Administration (FDA) sent regulatory letters to drug firms involved !:I the marketing of adrenal cortical extract praducts advising them that it considered these products to be unapproved new drugs and in violation of the Feder... |
| Date May 28, 1980 |
Report No. HRD-80-64 |
Title
BY THECOMPTROLLERGENERAL Report To The Subcommittee On Science, a Research, And Technology, House Committee On Science And Technology
OF THEUNITEDSTATES FDA Drug Approval--A Lengthy Process That Delays The Availability Of Important New Drugs
The average time required by the Food and Drug Administration to approve drugs--some of which could provide increased therapeutic benefits--is 20 months, incl... |
| Date June 19, 1979 |
Report No. 109679 |
Title
DNITEL STATES GENERAL ACCOUNTING I3.C. 20546 OFFICE WASHINGTON, FOR RELEASE GPj DELIVERY EXFECTEC AT lG:OO A.M. EDT JUNE 19, 1'379 GREGORY J. STATEMENT OF GIRECTOR, HUMAN RESOURCES CIVISION BEFORE THE COMMITTEE ON SCIENCE ANG TECHNOLOGY SUECOMMITTEE ON SCIENCE, RESEARCH ANC TECHNOLOGY OPi THE: FOOLj ANL; I;RUG ADMINISTRATION'S CRUG APFROVAL, YROCkSS AHART, J 109679 Mr.
Fleased our review Chairmen ... |
| Date May 1, 1979 |
Report No. HRD-79-73 |
Title
B-164031(5)
MAY 1,1979 The Konorable Bob Eckhardt U Chairman, Subcommittee on Oversight and Investigations House Committee on Interstate and Foreign Commerce
)” /~~o.zsu.~ JThe Ronorable Jack Brooks Chairman, House Committee on Government Operations b*r;he Honorable George E. Danielson Chairman, Subcommittee on Administrative Law and Governmental Relations House Committee on the Judiciary ,,.fjl... |
| Date Sept. 19, 1978 |
Report No. HRD-78-163 |
Title
DOCUMENT RESO8H
07115 - [B2647703] [Adequacy of HEB's Audit of Swine Flu Vaccine Hanufiacturing Costs]. HRD-78-163; B-164031(5). September 19, 1978. 3 pp. deport to Rep. George B. Danielsone Chairman, House Committee on the Judiciary: Administrative Law and Governmental Relations Subcommittee; Rep. Paul G. Rogers, Chairaar, House Committee on Interstate and Foreign Commerce: Health and the Environ... |
| Date March 2, 1978 |
Report No. EMD-78-45 |
Title
DoC G1IT RESO 05069 - B06655711 Plam; Oerationa. ID-78-45; arch 6, 1918. 6 pp. Department of Rnergy's Heavy iter B-164105. Marc 2 '78. Released Report to Rep. homas evill, Chairman, ousae Coittee on Appropriations: Public orks Sbcommittee b ll ,er . Staats Comptrollar Geeral.
Issue area: aterials: adiaistration and Coordination of Materials Policy (1812). contact: Energy and aiarals Div. Budget ft... |
| Date July 15, 1976 |
Report No. HRD-76-96 |
Title
Food and Drug /M-ministration Department of Health, Education, and Welfare The Food and Drug Administration has neither adequately monitored new drug tests nor adequately enforced compliance with testing requirements. Consequently, it lacks assurance (1) that the thousands of human subjects used in such tests annually are protected from unnecessary hazards of new drugs or (2) that the test data us... |
| Date Jan. 1, 1974 |
Report No. 091053 |
Title
|
| Date April 17, 1972 |
Report No. B-175425 |
Title
_I I , ’ , - REPQRT TO Illllllll lllllllllllllll IIIll Ill11 Ill11 llllllll
LM096596 Efforts To Prevent Dangerous Drugs From illicitly Reaching The Public B.175425
Bureau of Narcotics and Dangerous Drugs Department of Justice BY THE COMPTROLLER GENERAL OF THE UNITED STATES COMPTROLLER GENERAL
WASHINGTON. OF THE UNITED
20548 STATES D.C. B-175425 To the President Speaker of the This Narcotics to p... |
| Date June 10, 1971 |
Report No. B-171649 |
Title
I I I 0weYi-J prices o%feredto istIler custotierBa. We the to idle attention of VA o%ficials who i-i-xformedus brought these matters that VA bad increaeed ita sea%% spectiicalSy %OP the p-lmpofBe 0% monitoring contracts to deteTmigm whether the Government actxm~ly wan obtaining the economic advantagee o%%ered by- contractor i3 o The. ~amdts of OUT examination ale VA and Sigma ChemicaP Company rep... |
